No Data
No Data
Express News | Abbvie Inc : HSBC Raises Target Price to $230 From $215
AbbVie's (ABBV.US) CD3, CD20 dual-acting antibody acalabrutinib monoclonal antibody has applied for listing in China.
On November 6, the CDE website shows that AbbVie (ABBV.US)'s CD3/CD20 bispecific antibody epcoritamab, with the trade name Epkinly in the USA, has applied for listing in China.
Tuesday Market Closed Up, with Presidency in Sight | Wall Street Today
We Want YOU to Submit Questions for Election Night
Market Climbs for Election Day Excitement | Live Stock
AI Robot Trader Dumped Microsoft, Amazon Stocks and Went Defensive. Here's What It Bought.
No Data
No Data